Bloomington / Normal, IL

Working with the community... for a healthier community.

New Technology Saving Local Lives


Submitted by Ft. Jesse Imaging & Gale Keeran Center for Women

In 2016, Jan retired from a successful career and was looking forward to spending more time with family and friends. Her three children were scattered across the country, and she had plans to visit them.

However, her plans were put on hold in the spring of 2017.

Jan had been getting annual mammograms since the age of 40. In March 2017, Jan went to Ft. Jesse Imaging & Gale Keeran Center for Women in Bloomington for her annual 3D mammogram (tomosynthesis).

This time, Jan learned something new in her test results letter. The radiologist told her that she was among the forty percent of women who have dense breasts.

Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. The more connective tissue there is, the denser the breast tissue is and the whiter it will look on a mammogram. Both cancer and dense tissue show up white on a mammogram, so looking for tumors in women with dense breasts can be like looking for a snowball in a snowstorm. Due to this, cancers may be missed by radiologists.

Because of Jan’s high breast density, the doctor ordered an automated breast ultrasound (ABUS) exam to be sure they weren’t missing anything.

“ABUS is a great option for patients with dense breasts, in conjunction with mammography,” says Marie Stork R.T.(R)(M) lead mammography technologist at Ft. Jesse. “As technologists, we do our best to explain the benefits of the technology.”

Within a week, Jan received the unfortunate news: she had stage 1 breast cancer.

“I had never heard about dense breast tissue,” says Jan. “It came as a complete shock, but I was glad that there was technology available that could see through it and find my cancer early.”

The team at Ft. Jesse Imaging & Gale Keeran Center for Women, on average, performs about 25 ABUS exams every week.

Mammography may miss cancers in dense breasts; however, the Invenia ABUS from GE Healthcare has been proven to find more invasive cancers after a normal or benign mammographic finding.

“ABUS looks at the breast in a different way than the screening mammogram,” says Dr. Daniel Ha, Jan’s radiologist. “In Jan’s case, the ABUS could see through the density and detect a cancer that was not seen on her 3D mammogram. Even with the best mammogram available today, 3D mammography is still challenged in high breast density. For Jan, ABUS provided a more comprehensive way to look at the breast.”

Jan’s treatment plan included a lumpectomy, 33 radiation treatments, and oral chemotherapy drugs. Fortunately, she is doing well today. She will continue to get annual mammograms and ABUS exams.

“ABUS and screening mammograms are complementary to each other and, when combined, adds the best patient outcome,” says. Dr. Ha.

“If Jan hadn’t had the ABUS exam, her cancer would not have been detected until it was a palpable lesion found during a clinical exam or had become apparent on a mammogram. It might have been at a more advanced stage with less treatment options available.” “Following my cancer diagnosis, my mind went crazy thinking about whether my children would even have a mother, and whether I would get to meet my future grandchildren,” Jan says. “Mother’s Day was always a special occasion for me, but it’s become even more special in the last year, and I feel truly blessed.”

This article originally appeared on The Pulse, GE Healthcare’s newsroom:

Ft. Jesse Imaging and Gale Keeran Center for Women is the only outpatient imaging facility in the Bloomington-Normal area offering multiple modalities and a designated women’s center. Please call 309-454-5552 for information regarding your next imaging exam.